Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Mallinckrodt
McKesson
Harvard Business School
McKinsey

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091673

See Plans and Pricing

« Back to Dashboard

NDA 091673 describes ATAZANAVIR SULFATE, which is a drug marketed by Aurobindo Pharma Ltd, Cipla, Mylan, and Teva Pharms Usa, and is included in four NDAs. It is available from seven suppliers. Additional details are available on the ATAZANAVIR SULFATE profile page.

The generic ingredient in ATAZANAVIR SULFATE is atazanavir sulfate. There are twenty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atazanavir sulfate profile page.
Summary for 091673
Tradename:ATAZANAVIR SULFATE
Applicant:Teva Pharms Usa
Ingredient:atazanavir sulfate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 091673
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 091673 ANDA Teva Pharmaceuticals USA, Inc. 0093-5526 0093-5526-06 60 CAPSULE in 1 BOTTLE (0093-5526-06)
ATAZANAVIR SULFATE atazanavir sulfate CAPSULE;ORAL 091673 ANDA Teva Pharmaceuticals USA, Inc. 0093-5527 0093-5527-06 60 CAPSULE in 1 BOTTLE (0093-5527-06)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 100MG BASE
Approval Date:Apr 22, 2014TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 150MG BASE
Approval Date:Apr 22, 2014TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 200MG BASE
Approval Date:Apr 22, 2014TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Moodys
Merck
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.